14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CDTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Cidara Therapeutics stock price on Tuesday which ended trading at $0.513
(Updated on Apr 23, 2024)

Sell candidate since Apr 16, 2024 Loss -29.79% PDF

The Cidara Therapeutics stock price fell by -0.272% on the last day (Tuesday, 23rd Apr 2024) from $0.514 to $0.513. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 15.95% from a day low at $0.500 to a day high of $0.580. The price has fallen in 8 of the last 10 days and is down by -41.43% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $934.18 thousand.

Given the current short-term trend, the stock is expected to rise 18.79% during the next 3 months and, with a 90% probability hold a price between $0.609 and $1.42 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CDTX Signals & Forecast

There are few to no technical positive signals at the moment. The Cidara Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.672 and $0.791. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -55.82%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cidara Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0798 between high and low, or 15.95%. For the last week the stock has had daily average volatility of 14.37%.

Cidara Therapeutics is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CDTX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Cidara Therapeutics to open at $0.531, and during the day (based on 14 day Average True Range), to move between $0.403 and $0.622, which gives a possible trading interval of +/-$0.109 (+/-21.32%) up or down from last closing price. If Cidara Therapeutics takes out the full calculated possible swing range there will be an estimated 42.64% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.514, some $0.0014 (0.27%) from the current price of $0.513, our system finds the risk reward not very attractive.

Is Cidara Therapeutics stock A Buy?

The Cidara Therapeutics stock holds several negative signals and despite the positive trend, we believe Cidara Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.750 Strong Sell Candidate Downgraded

Predicted Opening Price for Cidara Therapeutics of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$0.531 ( 3.59%) $0.513

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CDTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.611 19.16 %
R2 0.580 13.21 %
R1 0.561 9.54 %
Current price: 0.513
Support S1 0.500 -2.36 %
S2 0.482 -6.03 %
S3 0.451 -11.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0.514 0.273 %
Current price 0.513
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Cidara Therapeutics Stock and on which exchange is it traded?
The symbol for Cidara Therapeutics is CDTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cidara Therapeutics Stock?
The Cidara Therapeutics stock holds several negative signals and despite the positive trend, we believe Cidara Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Cidara Therapeutics Stock?
Cidara Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cidara Therapeutics Stock.

What's the current price of Cidara Therapeutics Stock?
As of the end of day on the Apr 23, 2024, the price of an Cidara Therapeutics (CDTX) share was $0.513.

What is the 52-week high and low for Cidara Therapeutics Stock?
The 52-week high for Cidara Therapeutics Stock is $1.48 and the 52-week low is $0.500.

What is the market capitalization of Cidara Therapeutics Stock?
As of the Apr 23, 2024, the market capitalization of Cidara Therapeutics is 46.442M.

When is the next earnings date for Cidara Therapeutics?
The upcoming earnings date for Cidara Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Cidara Therapeutics

Cidara Therapeutics Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive... CDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT